Impaired Glucose Tolerance Completed Phase 4 Trials for Exenatide (DB01276)

Also known as: Prediabetic State (IGT) / Impaired Glucose Tolerance (IGT) / IGT - Impaired Glucose Tolerance / Glucose tolerance impaired / Impaired Glucose Tolerance (Prediabetes) / Pre-diabetic State / Prediabetic State / Pre-Diabetic / Pre Diabetes / Pre-Diabetes / Pre Diabetic / Prediabetes / Prediabetic / Latent diabetes / Chemical diabetes / Glucose intolerance / Malabsorption of glucose (disorder) / Impaired glucose tolerance (disorder) / Prediabetes (finding) / Borderline diabetes

IndicationStatusPhase
DBCOND0030184 (Impaired Glucose Tolerance)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00974272Effects of Exenatide on Postprandial Hyperlipidemia and InflammationTreatment
NCT00845182Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell FunctionTreatment
NCT00546728The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-DiabetesTreatment
NCT00456885The Effect of Exenatide on Weight and Hunger in Obese, Healthy WomenTreatment
NCT01588418Acute Effect of Exenatide on Brain Glucose MetabolismBasic Science
NCT02104739Effects of Antidiabetic Medications on the Postprandial State in PrediabetesTreatment